As re-expression of C/EBPα leads to proliferation arrest, differentiation, and increased apoptosis accompanied by morphological changes, it suggests that loss of C/EBPα may contribute to lung cancer development in humans [10, 11]. The gene discussed is CEBPA; the disease is lung carcinoma.